Clinical Trial: A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07128615) titled 'A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)' on Aug. 05.

Brief Summary: The purpose of this study is to evaluate the safety and immunogenicity of two investigational vaccines, AZD4117 and AZD5315 to protect against certain strains of avian Influenza A (H5N1 and H7N9 subtypes).

Study Start Date: Aug. 19

Study Type: INTERVENTIONAL

Condition: Influenza A

Intervention: BIOLOGICAL: AZD4117

Intramuscular (IM) injection

BIOLOGICAL: AZD5315

IM injection

OTHER: Placebo

IM injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Disclaimer: Curated by HT Syndication....